You are here

Oncogene DOI:

Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas

Publication TypeJournal Article
Year of Publication2008
AuthorsTakeyama, K, Monti, S, Manis, JP, Cin, DP, Getz, G, Beroukhim, R, Dutt, S, Aster, JC, Alt, FW, Golub, TR, Shipp, MA
JournalOncogene
Volume27
Issue3
Pages318 - 22
Date Published2008/01/10/
ISBN Number1476-5594
KeywordsAlleles, Cancer, Chromosome Aberrations, Chromosomes, Diffuse, Fluorescence, Gene Dosage, Gene Expression Profiling, Human, Humans, In Situ Hybridization, Intracellular Signaling Peptides and Proteins, Large B-Cell, Lymphoma, Oligonucleotide Array Sequen, Pair 15
Abstract

p53-Binding protein 1 (53BP1) encodes a critical checkpoint protein that localizes to sites of DNA double-strand breaks (DSBs) and participates in DSB repair. Mice that are 53bp1 deficient or hemizygous have an increased incidence of lymphoid malignancies. However, 53BP1 abnormalities in primary human tumors have not been described. By combining high-density single nucleotide polymorphism (HD SNP) array data and gene expression profiles, we found 9 of 63 newly diagnosed human diffuse large B-cell lymphomas (DLBCLs) with single copy loss of the chromosome 15q15 region including the 53BP1 locus; these nine tumors also had significantly lower levels of 53BP1 transcripts. 53BP1 single copy loss found with the HD SNP array platform was subsequently confirmed by fluorescence in situ hybridization. These studies highlight the role of 53BP1 copy loss in primary human DLBCLs and the value of integrative analyses in detecting this genetic lesion in human tumors.

URLhttp://www.ncbi.nlm.nih.gov/pubmed/17637749